Gingival crevicular fluid and interleukin-23 concentration in systemically healthy subjects: Their relationship in periodontal health and disease

Journal of Periodontal Research

Volumn 49, Issue 2, 2014, Pages 237-245

  Himani, G S ^a   Prabhuji, M L V ^b   Karthikeyan, B V ^b  

^a MGM Dental College and Hospital   (India)

^b Krishnadevaraya College of Dental Sciences and Hospital   (India)

Author keywords

Gingival crevicular fluid; Immunity; Interleukin 23; Periodontal disease

Indexed keywords

INTERLEUKIN 23;

ADULT; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; COHORT ANALYSIS; COMPARATIVE STUDY; DENTAL PLAQUE; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; PROCEDURES; PROSPECTIVE STUDY; TOOTH CALCULUS;

ADULT; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; COHORT STUDIES; DENTAL CALCULUS; DENTAL PLAQUE; DENTAL SCALING; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; INTERLEUKIN-23; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PROSPECTIVE STUDIES; ROOT PLANING;

EID: 84897631593     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12100     Document Type: Article

References (29)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
2. Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008;87:817-828.
3. Kim EY, Teh HS. TNF type 2 receptor (p75) lowers the threshold of T cell activation. J Immunol 2001;167:6812-6820.
4. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004;35:21-41.
5. Tang C, Chen S, Qian H, Huang W. IL-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135:112-124.
6. Shimozato O, Ugai S, Chiyo M et al. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 2006;117:22-28.
7. Ohyama H, Kato-Kogoe N, Kuhara A et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009;88:633-638.
8. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006;27:17-23.
9. Tan ZY, Bealgey KW, Fang Y, Gong YM, Bao S. Interleukin-23: immunological roles and clinical implications. Int J Biochem Cell Biol 2009;41:733-735.
10. Ribeiro VF, de Mendonca AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol 2011;82:1187-1196.
11. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005;32:369-374.
12. Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007;78:1545-1550.
13. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389.
14. Tsai CC, Ku CH, Ho YP, Ho KY, Wu YM, Hung CC. Changes in gingival crevicular fluid interleukin-4 and interferon-gamma in patients with chronic periodontitis before and after periodontal initial therapy. Kaohsiung J Med Sci 2007;23:1-7.
15. Santos VR, Ribeiro FV, Lima JA et al. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. J Periodontal Res 2012;47:45-54.
16. Araujo MW, Hovey KM, Benedek JR et al. Reproducibility of probing depth measurement using a constant-force electronic probe: analysis of inter- and intraexaminer variability. J Periodontol 2003;74:1736-1740.
17. Loe H, Silness J. Periodontal disease in pregnancy. I. prevalence and severity. Acta Odontol Scand 1963;21:533-551.
18. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
19. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 2008;180:5625-5635.
20. Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, Maslinski S. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 2010;71:134-145.
21. Caruso R, Fina D, Paoluzi OA et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008;38:470-478.
22. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49-56.
23. Pradeep AR, Hadge P, Chowdhry S, Patel S, Happy D. Exploring the role of Th1 cytokines: interleukin-17 and interleukin-18 in periodontal health and disease. J Oral Sci 2009;51:261-266.
24. Egelberg J, Attstrom R. Comparison between orifice and intracrevicular methods of sampling gingival fluid. J Periodontal Res 1973;8:384-388.
25. Santos VR, Ribeiro FV, Lima JA, Napimoga MH, Bastos MF, Duarte PM. Cytokine levels in sites of chronic periodontitis of poorly controlled and well-controlled type 2 diabetic subjects. J Clin Periodontol 2010;37:1049-1058.
26. Monnier VMGM, Elgawish A, Sell DR. The mechanism of collagen crosslinking in diabetes. A puzzle nearing resolution. Diabetes 1996;45(suppl 3):S67-S72.
27. Pashley DH. A mechanistic analysis of gingival fluid production. J Periodontal Res 1976;11:121-134.
28. Aliahmadi E, Gramlich R, Grutzkau A et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur J Immunol 2009;39:1221-1230.
29. Jafarzadeh A, Esmaeeli-Nadimi A, Nough H, Nemati M, Rezayati MT. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease. Anadolu Kardiyol Derg 2009;9:75-83.